Alembic seeks to mix it with US and European players

-

Alembic seeks to mix it with US and European players


Indian pharmaceutical firm Alembic is seeking to expand its presence in the lucrative US and European drug markets through an expanded partnering programme. 

The Gujarat-headquartered group, which is involved in both the active pharmaceutical ingredient (API) and pharmaceutical formulation markets, aims to grow internationally and double its annual turnover over the next two to three years, according to a report in India’s Business Standard.

Company director Pranav Amin explained that the firm intends to file about 10-12 ANDAs every year and to tap potential in the generic markets of the US and Europe. 

The company has also submitted around 22 drug master file (DMF) requests to regulatory agencies in Europe and the US in recent years in a bid to boost its roster of API clients.

Comments

Post a Comment

Popular posts from this blog

 Role of Blockchain in Healthcare Data Management

-
Image
ROLE OF BLOCKCHAIN IN HEALTHCARE DATA MANAGEMENT I n recent years, the healthcare industry has been undergoing a digital transformation, leveraging innovative technologies to improve patient care and data management.   One such technology that has gained significant attention is blockchain. Originally known for powering cryptocurrencies like Bitcoin, blockchain has found a remarkable application in healthcare data management.  This decentralized and secure ledger system holds immense potential to revolutionize the way sensitive medical information is stored, shared, and utilized across the healthcare ecosystem.  What is  Role of Blockchain in Healthcare Data Management? Blockchain technology has the potential to  revolutionize healthcare data management. It is a type of distributed ledger technology (DLT)  that leverages decentralized peer-to-peer computing, cryptography, and related technology to verify and propagate a chain of transaction records across a consortium, alliance, part
Read more

Demystifying AI in Drug Discovery: Transforming Pharma R&D

-
Image
Demystifying AI in Drug Discovery: Transforming Pharma R&D Artificial Intelligence (AI) has swiftly transformed industries, and drug discovery is no exception.  The pharmaceutical research and development (R&D) process has traditionally been lengthy, resource-intensive, and marked by high failure rates. However, with the advent of AI, a new era has dawned, promising to revolutionize the drug discovery landscape.  This article delves into the nuances of AI in drug discovery , exploring how it's reshaping pharma R&D processes and accelerating the journey toward innovative therapies. 1. Understanding AI in Drug Discovery: AI refers to the simulation of human intelligence in machines, enabling them to perform tasks that typically require human cognition, such as learning, reasoning, and problem-solving.  In drug discovery, AI algorithms analyze vast datasets to identify patterns, predict outcomes, and generate insights that aid in the identification and development of poten
Read more